High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Biomarker [clna]
trastuzumab [aapp, imft, phsu]
Induced [ftcn]
Cardiotoxicity [inpo]
HER-2 [aapp, enzy, rcpt]
Early Stage [clas]
Breast [bpoc]
Pilot Study [resa]
Monitoring [hlca]
Left ventricular ejection fraction [clna]
Current [tmco]
Standard [qlco]
Detection [topp]
trastuzumab [aapp, imft, phsu]
Induced [ftcn]
Cardiotoxicity [inpo]
Cost [qnco]
Assessment [hlca]
Suboptimal [qlco]
Women [popg]
early-stage breast cancer [neop]
Assessed [acty]
utility [orgt]
B-Type Natriuretic Peptide [aapp, horm, phsu]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Cardiac troponin I [aapp, bacs]
Biomarkers [clna]
Early Detection [diap]
trastuzumab [aapp, imft, phsu]
Induced [ftcn]
Cardiotoxicity [inpo]
Women [popg]
human epidermal growth factor receptor 2 [aapp, enzy, rcpt]
HER-2 [aapp, enzy, rcpt]
early-stage breast cancer [neop]
Relationship [qlco]
Elevated [qlco]
natriuretic peptide [aapp, horm, phsu]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Cardiac troponin I [aapp, bacs]
Levels [qlco]
decreases [qnco]
Left ventricular ejection fraction [clna]
Examined [fndg]
Left ventricular ejection fraction [clna]
monitor [hlca]
3 4 [fndg]
intervals [tmco]
trastuzumab [aapp, imft, phsu]
treatment [ftcn]
laboratory testing [lbpr]
Biomarkers [clna]
Repeated [ftcn]
3 Weeks [tmco]
Cycle [tmco]
trastuzumab [aapp, imft, phsu]
trastuzumab [aapp, imft, phsu]
Induced [ftcn]
Cardiotoxicity [inpo]
Defined [cnce]
Decrease [qlco]
Left ventricular ejection fraction [clna]
Thousand [qnco]
Value [qnco]
Decrease [qlco]
Left ventricular ejection fraction [clna]
Observed [ftcn]
Women [popg]
Abnormal [qlco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Thousand [qnco]
mg/L [qnco]
Predicted [idcn]
Decreased [qnco]
Left ventricular ejection fraction [clna]
Sensitivity [qnco]
Specificity [qnco]
CI 4 [aapp, phsu]
Subject [grup]
Normal [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
mg/L [qnco]
Negative [qlco]
predictive [qlco]
Suggest [idcn]
Normal [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
Low Risk [fndg]
Future [tmco]
Decreased [qnco]
Left ventricular ejection fraction [clna]
Association [menp]
B-Type Natriuretic Peptide [aapp, horm, phsu]
Cardiac troponin I [aapp, bacs]
Observed [ftcn]
False Positive [lbtr]
Cost [qnco]
Breast Cancer [neop]
Patients [podg]
adjuvant therapy [topp]
trastuzumab [aapp, imft, phsu]
Routine [qlco]
treatment [ftcn]
Traditional [ftcn]
Means [cnce]
Maximum [qnco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Value [qnco]
Observed [ftcn]
days [tmco]
Detection [topp]
Cardiotoxicity [inpo]
Decreased [qnco]
Left ventricular ejection fraction [clna]
Normal [qlco]
Levels [qlco]
Low Risk [fndg]
Cardiotoxicity [inpo]
Regular [qlco]
Monitoring [hlca]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Hold [idcn]
promise [idcn]
Biomarker [clna]
Women [popg]
early-stage breast cancer [neop]
Low Risk [fndg]
Asymptomatic [fndg]
trastuzumab [aapp, imft, phsu]
Induced [ftcn]
Cardiotoxicity [inpo]
Knowledge [inpr]
Study [mnob]
documenting [hlca]
utility [orgt]
expense [qnco]
Reproducibility [qlco]
Easily [qlco]
Biomarker [clna]
Rapid [qlco]
Evaluate [ftcn]
Cardiotoxicity [inpo]
trastuzumab [aapp, imft, phsu]
therapy [ftcn]
